targeting molecular and genetic abnormalities in cll
Published 9 years ago • 301 plays • Length 25:02Download video MP4
Download video MP3
Similar videos
-
20:59
targeted inhibition of signal molecules as novel therapy for cll
-
22:23
the bcr signaling pathway in cll
-
27:28
risk assessment in cll treatment
-
24:59
genomics 101 in cll: how useful in clinical practice?
-
17:59
ethnic, environmental, genetic, and familial risk factors for cll
-
24:17
combination of novel agents in cll: is this the final answer?
-
23:23
causes and consequences of genetic abnormalities in chronic lymphocytic leukemia
-
22:27
familial cll: increasing?
-
21:05
cll: optimal approaches for patients with deletion 17p
-
21:19
other new molecules in the cll pipeline: pi3k inhibitors, syk inhibitors, etc.
-
27:18
novel treatment options in cll
-
16:52
genetic basis of atypical chronic myeloid leukemia (cml)
-
21:31
bcr inhibitors in cll and lymphoma
-
1:44
the molecular and microenvironmental basis of immunodysfunction in cll
-
30:55
immune function in cll: what is wrong and why?
-
21:19
cll: sequencing monotherapy vs. combination therapy
-
23:41
expert perspectives: chronic lymphocytic leukemia (cll)
-
21:58
prince family lecture: clonal evolution in cll
-
0:39
dr. jennifer brown on mutations and targets in cll